ETPharma.com brings latest cvs health news, views and updates from all top sources for the Indian Pharma industry.

CSL has signed a $1.6 billion agreement with Alentis Therapeutics to co-develop a groundbreaking treatment for rare kidney and liver diseases, aiming to revolutionize care with lixudebart.

Vaxcyte's late-stage study shows its pneumococcal vaccine VAX-31 meets efficacy benchmarks, boosting shares significantly. The vaccine demonstrates strong immune responses and safety for adults 50 and ...

The Serum Institute of India announces that its HPV vaccine, Cervavac, has received pre-qualification status from WHO, ...

Discover how three pioneering scientists are revolutionizing neuroscience with their research into brain mechanisms and ...

Aurobindo Pharma has gained FDA approval to market Perampanel tablets, an innovative drug for treating epilepsy, projected to ...

An investigation reveals the international ties of a Bengaluru fake medicine racket involving kingpin R Prashanth Babu and ...

ETPharma.com brings latest pharma stocks news, views and updates from all top sources for the Indian Pharma industry.

The Drugs Consultative Committee in India evaluates a proposal to halt mercury-added antiseptics like mercurochrome, ...

ETPharma.com brings latest regulatory approvals news, views and updates from all top sources for the Indian Pharma industry.

Delhi’s RML Hospital has recalled medicines including sodium valproate and spironolactone after quality failures. Departments mandated to stop use and return defective batches. No adverse effects ...

The Department of Pharmaceuticals has sanctioned ₹1600 crore for 41 innovative pharma and medtech projects, aiming to advance research and development in critical health areas. Private investments ...